# Cabergoline

NDC: 69238-2693
Generic name: Cabergoline
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20241003

FDA application: ANDA218618

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-2693"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-2693
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a246b015-e19c-4b4f-9089-aea1108687ba